The Combination of Bcl-2 Inhibitor Venetoclax and Mcl-1 Inhibitor MIK665 induces Cell Death in HCC Cells

被引：0
|
作者：
Walz, Franziska [1 ]
Michalski, Marlen [1 ]
Aschenbrenner, Elisabeth [1 ]
Mueller-Schilling, Martina [1 ]
Guelow, Karsten [1 ]
机构：
[1] Univ Klinikum Regensburg, Klin & Poliklin Innere Med 1, Regensburg, Germany
来源：
INTERNIST | 2022年 / 63卷 / SUPPL 3期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PS041
引用
收藏
页码：328 / 329
页数：2
相关论文
共 50 条
  • [1] MIK665/S64315, a novel Mcl-1 inhibitor, in combination with Bcl-2 inhibitors exhibits strong synergistic antitumor activity in a range of hematologic malignancies
    Halilovic, Ensar
    Chanrion, Maia
    Mistry, Prakash
    Wartmann, Markus
    Qiu, Shumei
    Sanghavi, Sneha
    Chen, Yan
    Lysiak, Gaelle
    Maragno, Ana Leticia
    Pfaar, Ulrike
    Huth, Felix
    Schoumacher, Marie
    Claperon, Audrey
    Kraus-Berthier, Laurence
    Banquet, Sebastien
    Derreal, Alix
    Maacke, Heiko
    Colland, Frederic
    Geneste, Olivier
    Morris, Erick
    Wang, Youzhen
    CANCER RESEARCH, 2019, 79 (13)
  • [2] Statins Enhance Killing of Multiple Myeloma Cells By the BCL-2 Inhibitor Venetoclax and the MCL-1 Inhibitor S63845
    Fruman, David
    Juarez, Dennis
    Diep, Grace
    Nguyen, Falisha
    Gupta, Vikas A.
    Boise, Lawrence H.
    BLOOD, 2019, 134
  • [3] High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition
    Bate-Eya, Laurel T.
    den Hartog, Ilona J. M.
    van der Ploeg, Ida
    Schild, Linda
    Koster, Jan
    Santo, Evan E.
    Westerhout, Ellen M.
    Versteeg, Rogier
    Caron, Huib N.
    Molenaar, Jan J.
    Dolman, M. Emmy M.
    ONCOTARGET, 2016, 7 (19) : 27946 - 27958
  • [4] Simultaneous Inhibition of Mcl-1 and Bcl-2 Induces Synergistic Cell Death in Hepatocellular Carcinoma
    Michalski, Marlen
    Bauer, Magdalena
    Walz, Franziska
    Tuemen, Deniz
    Heumann, Philipp
    Stoeckert, Petra
    Gunckel, Manuela
    Kunst, Claudia
    Kandulski, Arne
    Schmid, Stephan
    Mueller, Martina
    Guelow, Karsten
    BIOMEDICINES, 2023, 11 (06)
  • [5] Targeting AML through apoptosis activation using Bcl-2/Mcl-1 or Bcl-2/Hdm2 inhibitor combination therapies
    Wang, Youzhen
    Qui, Shumei
    Sanghavi, Sneha
    Mulford, Lain
    Lysiak, Gaelle
    Chanrion, Maia
    Mistry, Prakash
    Pfaar, Ulrike
    Schoumacher, Marie
    Claperon, Audrey
    Kraus-Berthier, Laurence
    Banquet, Sebastien
    Derreal, Alix
    Fabre, Claire
    Maacke, Heiko
    Colland, Frederic
    Geneste, Olivier
    Morris, Erick
    Halilovic, Ensar
    CANCER RESEARCH, 2019, 79 (13)
  • [6] Fibroblast growth factor receptor inhibitor erdafitinib promotes Mcl-1 degradation and synergistically induces apoptosis with Bcl-xL/Bcl-2 inhibitor in urothelial cancer cells
    Ohtsu, Akira
    Arai, Seiji
    Sawada, Tatsuhiro
    Kato, Mai
    Maeno, Yuta
    Miyazawa, Yoshiyuki
    Fujizuka, Yuji
    Sekine, Yoshitaka
    Koike, Hidekazu
    Matsui, Hiroshi
    Suzuki, Kazuhiro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 628 : 76 - 83
  • [7] Upregulation of MAPK/MCL-1 Maintaining Mitochondrial Oxidative Phosphorylation Confers Acquired Resistance to BCL-2 Inhibitor Venetoclax in AML
    Zhang, Qi
    Han, Lina
    Shi, Ce
    Pan, Rongqing
    Ma, Man Chun John
    Ryan, Jeremy
    Kurtz, Stephen E.
    Mu, Hong
    Ruvolo, Vivian
    Ma, Helen
    Andreeff, Michael
    Mi, Yingchang
    Tyner, Jeffrey W.
    Leverson, Joel
    Letai, Anthony
    Davis, Richard Eric
    Konopleva, Marina
    BLOOD, 2016, 128 (22)
  • [8] The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA
    Weller, Sandra
    Toenniessen, Astrid
    Schaefer, Benjamin
    Beigl, Tobias
    Muenchow, Alina
    Bopple, Kathrin
    Hofmann, Ute
    Gillissen, Bernhard F.
    Aulitzky, Walter E.
    Kopp, Hans-Georg
    Essmann, Frank
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [9] The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA
    Sandra Weller
    Astrid Toennießen
    Benjamin Schaefer
    Tobias Beigl
    Alina Muenchow
    Kathrin Böpple
    Ute Hofmann
    Bernhard F. Gillissen
    Walter E. Aulitzky
    Hans-Georg Kopp
    Frank Essmann
    Cell Death Discovery, 8
  • [10] Marine Polyether Phycotoxin Palytoxin Induces Apoptotic Cell Death via Mcl-1 and Bcl-2 Downregulation
    Kim, Jaemyun
    Ji, Seungwon
    Lee, Jin-Young
    Lorquin, Jean
    Orlikova-Boyer, Barbora
    Cerella, Claudia
    Mazumder, Aloran
    Muller, Florian
    Dicato, Mario
    Detournay, Olivier
    Diederich, Marc
    MARINE DRUGS, 2023, 21 (04)
12345